Abstract: An exchanger conduit permits temperature and/or humidity conditioning of a gas for a patient respiratory interface. In an example embodiment, a conduit has a first channel and a second channel where the first channel is configured to conduct an inspiratory gas and the second channel configured to conduct an expiratory gas. An exchanger is positioned along the first channel and the second channel to separate the first channel and the second channel. The exchanger is configured to transfer a component (e.g., temperature or humidity) of the gas of the second channel to the gas of the first channel. In some embodiments, an optional flow resistor may be implemented to permit venting at pressures above atmospheric pressure so as to allow pressure stenting of a patient respiratory system without a substantial direct flow from a flow generator of respiratory treatment apparatus to the patient during patient expiration.

Abstract: An automated drug delivery and monitoring system for use on mechanically ventilated patients in the intensive care unit is presented. Medication in the form of respirable particles is transported through ventilator circuitry by a delivery unit. Multiple medications may be delivered into the gas flow of the ventilator, with each medication delivered in a defined dose for a frequency and interval as specified by an operator. The particles mixed into the gas flow of the ventilator are inhaled and ingested by the patent's lungs.

Abstract: A patient interface includes a plenum chamber pressurisable to a therapeutic pressure, and a seal-forming structure constructed and arranged to seal with a region of a patient's face surrounding an entrance to a patient's airways. The seal-forming structure is constructed and arranged to maintain the therapeutic pressure in the plenum chamber throughout a patient's respiratory cycle in use. The patient interface also includes a positioning and stabilizing structure configured to hold the seal-forming structure in a therapeutically effective position on a patients head. The positioning and stabilizing structure includes a rear strap arranged to contact an occiput of the patient's head. The rear strap is constructed from a first material is arranged to contact a temporal region of the patient's head, and a second material arranged to contact the occiput of the patients head. The second material is silicone.

Abstract: A respiratory treatment apparatus and method in which a leak is determined by using an averaging window. The window starts at the present time and extends back in time to a point determined according to a current one of progressively detected phase measures of a first respiratory cycle and a corresponding phase measure attributable to a preceding second respiratory cycle. In another aspect, a jamming index indicates whether the leak is rapidly changing. To the extent that jamming is high, the leak estimate used progressively changes from that using sliding breath-window averaging to a more robust and faster responding low-pass filter method, and adjustment of ventilatory support based on measures employing estimated respiratory flow is slowed down or stopped.

Abstract: A patient interface structure includes a cushion configured to sealingly engage the patient's face and a front that is more rigid than the cushion. The cushion includes a forward opening, a rearward opening that is opposite the forward opening and a continuous sealing surface. The continuous sealing surface has a mouth sealing portion configured to seal around the patient's mouth and a nasal sealing portion configured to seal around both of the patient's nasal airways. The front plate includes an air inlet configured to both receive the pressurized respiratory gas and secure headgear to the patient interface structure. In addition, the nasal sealing portion includes at least one aperture that is separate from the rearward opening. Also, the front plate, the mouth sealing portion and the nasal sealing portion together form a common chamber.

Abstract: This disclosure describes systems and methods for providing drive pressure ventilation of a patient. The disclosure describes a novel breath type that provides a spontaneous breath type that allows for the calculation of drive pressure that does not require invasive monitoring.

Abstract: A system 10 for delivering respiratory therapy to a patient includes a patient interface device 20 for delivering pressurized gas to a patient, a connector system 60 for connection to a source of pressurized gas and a conduit system 40 fluidly connecting the connector system 60 to the patient interface device 20. The connector system 60 includes a plurality of closable ports 68, 32 that allow a plurality of different modes of respiratory therapy to be provided. The conduit system 40 may include a first gas line 42, a second gas line 46 and a third gas line 46. The second gas line 46 and third gas line 44 may be contained within the first gas line 42 along at least part of their length.

Abstract: There is provided a flexible, helically wound conduit for a breathing circuit. The conduit includes an inlet, an outlet, and an enclosing wall defining a flow passage between the inlet and the outlet, wherein at least a region of the enclosing wall is permeable to water vapor and one or more of O2 and CO2. The axial tensile strength of the enclosing wall is greater than 40N. Further provided are limbs comprising the conduit, a method of manufacturing the conduit and the use of the conduit to remove water vapor and/or CO2 from gas exhaled by a patient.

Abstract: Leakage components are described herein. The leakage component includes a first tubing housing and a plurality of leakage ports. The first tubular housing defines a first flow path between a first end portion and a second end portion. The plurality of leakage ports are formed in the first housing and in fluid communication with the first flow path. The fluid flow through the plurality of leakage ports is configured to entrain ambient air into the fluid flow exiting the plurality of leakage ports to decelerate the fluid flow.

Abstract: The invention provides a method of treating a subject having a medical condition associated with a pathogenic microorganism, the method comprising administering to said subject a potentiating effective amount of nitric oxide; and administering to said subject a therapeutically effective amount of an antimicrobial agent, wherein said antimicrobial agent is other than said nitric oxide.

Abstract: A patient interface comprises a support structure and a seal-forming structure. The support structure is arranged to support the sealing portion and is configured to connect to the frame. The sealing portion comprises textile and is attached to the support structure along an outer perimeter of the sealing portion such that in use the sealing portion may be in tension due to reactive stress of the support structure and/or a resilient stretch characteristic of the textile such that the sealing portion exerts a force against the patient's face.

Abstract: Flexible intubation assemblies and methods for using and making the same are provided.

Abstract: A gas delivery conduit adapted for fluidly connecting to a respiratory gases delivery system in a high flow therapy system. In one embodiment, a nasal cannula includes a base portion defining a first therapeutic gas passageway, a nozzle disposed adjacent said base portion and defining a second therapeutic gas passageway, the first passageway being in gaseous communication with the second passageway and a conduit configured to facilitate sensing that has an inlet side that is independent of and axially spaced apart from an outlet side of the nozzle. The conduit inlet side can extend beyond the nozzle outlet side of the nasal cannula. Additionally, the nasal cannula has a feature adapted to prevent one of the conduit and the nozzle from creating a seal with a user's nare and a feature adapted to prevent one of the conduit and the nozzle from creating a seal with a user's nare.

Abstract: A breathing mask includes a rigid member, an elastic member, and a foam member. The rigid member has an interface on the side away from the user's face for accessing the breathing gas of the continuous positive airway pressure device, and a flared joint on the side adjacent to the user's face. The elastic member is in communication with the inner cavity of the rigid member and is fixedly connected to the flared joint. The side of the elastic piece adjacent to the user's face at least partially abuts the user's nasal bridge area to form an elastic body part, and a support part connected to the elastic body part is provided on the side of the elastic member adjacent to the user's face. The foam member is fixed to the support part and, together with the elastic member, forms a sealing surface for fitting the user's face.

Abstract: Disclosed is an ICU-special portable nebulization device enabling autonomous respiration according to airflow, which includes a nebulization control host, a nebulization generator provided on the nebulization control host, and a tee connecting pipe provided on the nebulization generator; the nebulization generator comprises a bottom housing, a medicinal solution tank provided on the bottom housing and spaced apart from a space of the bottom housing, a medicinal solution outlet provided on the bottom of the medicinal solution tank, an air guide port provided on the bottom housing at the same side as the medicinal solution outlet, a nozzle tube sheathed on the periphery of the medicinal solution outlet and the air guide port, a partition provided in the nozzle tube which separates the medicinal solution outlet and the air guide port.

Abstract: An oscillating positive expiratory pressure apparatus having a housing defining a chamber, a chamber inlet, a chamber outlet, a deformable restrictor member positioned in an exhalation flow path between the chamber inlet and the chamber outlet, and an oscillation member disposed within the chamber. The deformable restrictor member and the oscillation member are moveable between an engaged position, where the oscillation member is in contact with the deformable restrictor member and an disengaged position, where the oscillation member is not in contact with the deformable restrictor member. The deformable restrictor member and the oscillation member move from the engaged position to the disengaged position in response to a first exhalation pressure at the chamber inlet, and move from the disengaged position to an engaged position in response to a second exhalation pressure at the chamber inlet.

Abstract: Ventilation masks are described herein. A ventilation mask includes a mask body and a gas manifold. The mask body defines a patient cavity and further includes a patient opening in fluid communication with the patient cavity; and at least one vent opening formed through the mask body, the at least one vent opening in fluid communication with the patient cavity, wherein the at least one vent opening is disposed generally opposite to the patient opening. The gas manifold is coupled to the mask body. The gas manifold can define a gas channel. The gas manifold can include a plurality of vectored gas ports in fluid communication with the gas channel, wherein the plurality of vectored gas ports are configured to create a curtain effect gas flow within the patient cavity to form a gas curtain within the patient cavity and adjacent to the at least one vent opening.

Abstract: This disclosure provides an endotracheal tube with a tip suitable for traversing the laryngeal inlet and with a guiding channel having a proximal opening adjacent a proximal end portion and a distal opening adjacent to a tip, wherein the guiding channel is adjacent a sidewall of the main lumen of the tube, which allows more accurate wire-guided intubation of a patient, a method and a kit relating to the same.

Abstract: A high flow nasal therapy system (1) has a gas supply (2), a nebulizer (12), and a nasal interface (7). There are two branches (11, 10) and a valve (6) linked with the controller, the branches including a first branch (11) for delivery of aerosol and a second branch (10) for delivery of non-aerosolized gas. The controller controls delivery into the branches (11, 10), in which flow is unidirectional in the first and second branches, from the gas supply towards the nasal interface. The first branch (11) includes the nebulizer (12) and a line configured to store a bolus of aerosol during flow through the second branch (10). The valve (6) comprises a Y-junction between the gas inlet on one side and the branches on the other side.

Abstract: A high flow therapy system for delivering heated and humidified respiratory gas to an airway of a patient includes a respiratory gas flow pathway for delivering the respiratory gas to the airway of the patient by way of a non-sealing respiratory interface; wherein flow rate of the respiratory gas is controlled by a microprocessor, a mixing area for mixing a first gas and a second gas in the respiratory gas flow pathway, a humidification area downstream of the mixing area and configured for humidifying respiratory gas in the respiratory gas flow pathway, and a heated delivery conduit for minimizing condensation of humidified respiratory gas.